Jinaine Pharmaceutics Announces Preliminary Designation as a Non-Compliant Disclosure Corporation
[Asia Economy Reporter Oh Ju-yeon] The Korea Exchange KOSDAQ Market Division announced on the 12th that it will designate Jinain Pharmaceutical as an unfaithful disclosure company due to failure to fulfill disclosure obligations, including four delayed disclosures of loan principal and interest arrears.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- National Tax Service to Recruit 9,500 Temporary Employees for "Verification of 130 Trillion Won in Delinquencies"
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
